An innovative drug research and development company sought Freyr’s expertise in the package preparation and submission of Type-B Pre-IND Meetings to the US FDA. Since the client did not have prior submission experience of Type-B pre-IND submissions.
Freyr’s CMC team assisted the client and helped them to get a comprehensive understanding and probable response to the Health Authorities i.e. US FDA. Download the proven case now.
Fill the form below to download the Case Study
